Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
British Columbia Cancer Agency
Scientific Title
A Phase II, Randomized, Multi-center Study of Cabazitaxel Versus Abiraterone or Enzalutamide in Poor Prognosis-metastatic Castration-resistant Prostate Cancer